Sign in
4

Changes in Ownership

REVIVA PHARMACEUTICALS HOLDINGS, INC. Filed Acc 0001437749-26-009258

Options or other derivatives

  • President and CEO acquired 150,075 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bhat Laxminarayan · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-18 Grant or award : show line 1 in the form Stock Option (right to buy) +109,150 109,150 D
2026-03-18 Grant or award : show line 2 in the form Stock Option (right to buy) +40,925 40,925 I
Loading xslF345X06/rdgdoc.xml…